Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Abroad (travel likely)Recruiting

Conditions

Type 2 Diabetes Mellitus (T2DM) · Type 2 Diabetes · Diabetes Mellitus · Hypertension · Hyperglycemia · Hyperlipidemia · Dyslipidemia · Hyperuricemia or Gout · Hyperuricemia, Gout · Obesity · Obesity/Epidemiology · Obesity, Abdominal · Central Obesity · Visceral Fat · Chronic Kidney Disease(CKD) · Atherosclerosis · Metabolic Syndrome · Hepatic Steatosis · Insulin Sensitivity/Resistance

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The Ohtori Health Promotion Center, Sakai, Osaka, Japan

    Contact: Study coordinator (Yonezo Hikita, MD, PhD) · ocespart2@gmail.com
Study leads
  • Tomoshige Hayashi, MD, PhD

    Principal Investigator

    Osaka Metropolitan University